Aptar Pharma has announced the official opening of its new 7,000 sq m manufacturing facility in Mumbai, India. Aptar has been manufacturing MDI valves and pumps at the site since 2012. According to Aptar, the capabilities there “have now been expanded to offer more innovative product solutions and ensure increased manufacturing capacity to pharma customers in South East Asia.” Groundbreaking for the Mumbai expansion project took place in January 2022.
Aptar Pharma President Gael Touya commented, “Our Aptar Pharma business in India has shown robust growth in recent years, and today marks yet another milestone in our investment in the South East Asia region. Over the past 11 years, Aptar Mumbai has continuously supplied safe, high-quality products that meet even the highest of regulatory requirements. This new facility is a key step in serving the needs of our customers in the region, which will ultimately benefit patients.”
President, India & Head, Pharma – SEA, Sanjay Kapote said, “This new site in Mumbai provides a larger space, not only for the expansion of our well-established assembly operations, but also to fuel further localization and support our vision of bringing in other Aptar Pharma technologies suitable for the Asian market.”
Read the Aptar Pharma press release.
